{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:25Z","timestamp":1791357205390,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.psychres.2014.04.049","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T22:17:26Z","timestamp":1399587446000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine"],"prefix":"10.1016","volume":"218","author":[{"given":"Jari-Pekka","family":"Klemettil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"Viikki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.04.049_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genm.2012.01.002","article-title":"Sex differences in the association of adiponectin and low-grade inflammation with changes in the body mass index from youth to middle age","volume":"9","author":"Ahonen","year":"2012","journal-title":"Gender Medicine"},{"key":"10.1016\/j.psychres.2014.04.049_bib2","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2014.04.049_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4088\/JCP.v68n1202","article-title":"Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia","volume":"68","author":"Bai","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0269881112440512","article-title":"A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications","volume":"26","author":"Beary","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib5","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2014.04.049_bib6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3945\/ajcn.2008.27030","article-title":"Sex differences in inflammatory markers: what is the contribution of visceral adiposity?","volume":"89","author":"Cartier","year":"2009","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.psychres.2014.04.049_bib7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.pnpbp.2011.07.014","article-title":"Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia","volume":"35","author":"Chen","year":"2011","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"key":"10.1016\/j.psychres.2014.04.049_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2012.06.040","article-title":"Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein","volume":"140","author":"Dieset","year":"2012","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2010.02.1028","article-title":"Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia","volume":"118","author":"Fan","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.psychres.2014.04.049_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-na\u00efve individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5551\/jat.3939","article-title":"Adipose tissue, inflammation and atherosclerosis","volume":"17","author":"Gustafson","year":"2010","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/j.psychres.2014.04.049_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","article-title":"A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder","volume":"106","author":"Hanssens","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2011.12.010","article-title":"The adipocyte as an endocrine organ in the regulation of metabolic homeostasis","volume":"63","author":"Harwood","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.genhosppsych.2009.07.008","article-title":"Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors","volume":"31","author":"Kilbourne","year":"2009","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","article-title":"Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever","volume":"34","author":"Kluge","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2014.04.049_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ijo.2011.20","article-title":"Lack of association between body mass index and plasma adiponectin levels in healthy adults","volume":"35","author":"Kuo","year":"2011","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.psychres.2014.04.049_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0269881111431622","article-title":"The metabolic syndrome in schizophrenia: is inflammation a contributing cause?","volume":"26","author":"Leonard","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/JCP.0b013e3181eeb7f7","article-title":"Clozapine mobilizes CD34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia","volume":"30","author":"L\u00f6ffler","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0b013e32833643fd","article-title":"Clozapine therapy raises serum concentrations of high sensitive c-reactive protein in schizophrenic patients","volume":"25","author":"L\u00f6ffler","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib25","first-page":"1251","article-title":"Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia","volume":"24","author":"Lu","year":"2004","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"10.1016\/j.psychres.2014.04.049_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2796.2010.02294.x","article-title":"Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes","volume":"269","author":"Luotola","year":"2011","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.psychres.2014.04.049_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","article-title":"in vivo immunomodulatory effects of clozapine in schizophrenia","volume":"29","author":"Maes","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/met.2010.0106","article-title":"Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey","volume":"9","author":"Malo","year":"2011","journal-title":"Metabolic Syndrome and Related Disorders"},{"key":"10.1016\/j.psychres.2014.04.049_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2265.2012.04384.x","article-title":"Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study)","volume":"78","author":"Marques-Vidal","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.psychres.2014.04.049_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1819.2005.01370.x","article-title":"Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia","volume":"59","author":"Matsuda","year":"2005","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.psychres.2014.04.049_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and b cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.psychres.2014.04.049_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.psychres.2014.04.049_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia","volume":"7","author":"Miller","year":"2014","journal-title":"Clinical Schizophrenia & Related Psychoses"},{"key":"10.1016\/j.psychres.2014.04.049_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbi.2012.08.016","article-title":"Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses","volume":"31","author":"Miller","year":"2013","journal-title":"Brain, Behaviour, and Immunity"},{"key":"10.1016\/j.psychres.2014.04.049_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders \u2013 a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2014.04.049_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-1781(97)00036-X","article-title":"Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment","volume":"16","author":"Monteleone","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2014.04.049_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3858\/emm.2012.44.9.062","article-title":"Inhibition of mouse brown adipocyte differentiation by second- generation antipsychotics","volume":"44","author":"Oh","year":"2012","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.psychres.2014.04.049_bib40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-na\u00efve schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diabetes & Metabolism"},{"key":"10.1016\/j.psychres.2014.04.049_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia in Stockholm county, Sweden","volume":"45","author":"Osby","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.metabol.2009.04.038","article-title":"The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations","volume":"58","author":"Plaisance","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.psychres.2014.04.049_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollm\u00e4cher","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.08.036","article-title":"Functional and structural features of adipokine family","volume":"61","author":"Raucci","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.psychres.2014.04.049_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","article-title":"Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia","volume":"26","author":"Richards","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10654-012-9671-0","article-title":"Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations","volume":"27","author":"Rossi","year":"2012","journal-title":"European Journal of Epidemiology"},{"key":"10.1016\/j.psychres.2014.04.049_bib48","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/dc06-0147","article-title":"Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects","volume":"29","author":"Ruotsalainen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psychres.2014.04.049_bib49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2014.04.049_bib50","doi-asserted-by":"crossref","first-page":"e10100","DOI":"10.1371\/journal.pone.0010100","article-title":"Thirty novel biomarkers as predictors for clinically incident diabetes","volume":"5","author":"Salomaa","year":"2010","journal-title":"PLOS One"},{"key":"10.1016\/j.psychres.2014.04.049_bib51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/eje.1.02287","article-title":"Low plasma adiponectin concentration is an indicator of the metabolic syndrome","volume":"155","author":"Santaniemi","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.psychres.2014.04.049_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/nedt.1.2.171.61048","article-title":"Increased serum interleukin-1beta and interleukin -6 in elderly, chronic schizophrenic patients on stable antipsychotic medication","volume":"1","author":"Schmitt","year":"2005","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.psychres.2014.04.049_bib53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1373\/clinchem.2008.117754","article-title":"Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents","volume":"55","author":"Shen","year":"2009","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.psychres.2014.04.049_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.yfrne.2009.03.004","article-title":"Sexual differences in the control of energy homeostasis","volume":"30","author":"Shi","year":"2009","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.psychres.2014.04.049_bib55","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1016\/j.jaci.2005.07.001","article-title":"Cytokines and chemokines","volume":"117","author":"Steinke","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.psychres.2014.04.049_bib56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182524393","article-title":"Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia","volume":"32","author":"Sugai","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of inflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"17","author":"Sugino","year":"2009","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4088\/JCP.v68n0711","article-title":"Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey","volume":"68","author":"Suvisaari","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.04.049_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-200401000-00007","article-title":"Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study","volume":"19","author":"Togo","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2011.03.010","article-title":"Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study","volume":"22","author":"Wampers","year":"2012","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.04.049_bib62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000122267","article-title":"Increased plasma leptin in antipsychotic-na\u00efve females with schizophrenia, but not in males","volume":"56","author":"Wang","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2014.04.049_bib63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.ijo.0803750","article-title":"Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity","volume":"32","author":"Wu","year":"2008","journal-title":"International Journal of Obesity"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T04:55:00Z","timestamp":1538628900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178114003631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0165178114003631"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.04.049","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}